Compare Illumina, Inc. (ILMN) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while KraneShares Electric Vehicles and Future Mobility trades at $27.86 (market cap $72.36M). The key difference: Illumina, Inc. is far larger — about 552.1× KraneShares Electric Vehicles and Future Mobility's market cap, and Illumina, Inc. is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and KraneShares Electric Vehicles and Future Mobility for 46 Days on average.
| ILMN | KARS | |
|---|---|---|
Market Cap | $39.95B | $72.36M |
Volume | 3,169,503 | 5,034 |
Sector | Health | Sector/Thematic |
52-Week High | $293.69 | $38.01 |
52-Week Low | $91.00 | $27.25 |
Typical Hold Time | 83 Days | 46 Days |
Enterprise Value | $41.31B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ILMN trades at $264.40, down 1.25% on the day, but remains near its recent 52-week high of $278.99 (Defense World, 2026-10-01). The stock has surged 94.9% year-to-date (Zacks Investment Research, 2026-09-24), supported by strong earnings beats in recent quarters and a bullish technical trend. Fundamentals show a significant turnaround, with 2025 net income reaching $850 million after prior losses, though valuation ratios like a P/E of 49.36 are elevated. The pending inclusion in the S&P 500 (PRNewsWire, 2026-09-04) adds a positive catalyst.
The outlook is positive, driven by sequencing growth, AI integration in genomics, and improved profitability. However, risks include high valuation sensitivity, cost volatility, and competitive pressures in the life sciences sector. Analyst consensus is bullish with a 54% buy rating, but the average price target of $241 suggests limited near-term upside from current levels.
KARS trades at $27.86, up 0.25% with a bearish technical signal from moving averages. The stock shows neutral oscillator readings with RSI at 54.12 and 45.15, while ADX indicates mixed trend strength. Support and resistance cluster around $28-$29 levels, suggesting potential consolidation. Recent news highlights mixed EV market trends with US sales lagging while global demand grows.
The outlook remains cautious given bearish technical signals and mixed EV market dynamics. Investment opportunity exists in global EV growth trends, but risks include US market headwinds and regulatory uncertainty. Stock performance may depend on company-specific execution amid evolving industry conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
